ACROPETAL

Members of the Exchange are hereby notified that in terms of Regulation 22(6) of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, Section 21A of the Securities Contract (Regulations) Act, 1956, Rule 21(2) b of Securities Contract (Regulations) Rules, 1957 , it has been decided to delist (withdraw the admission to dealings in) equity shares of the Acropetal Technologies Limited w.e.f. August 08, 2018 as per Chapter V of SEBI (Delisting of Equity Shares) Regulations, 2009.

Members of the Exchange are hereby informed that the Exchange on February 28, 2018 has issued public notice in the newspaper for�� proposed compulsory delisting of equity shares of the company, in term of Regulation 22 (3) of SEBI (Delisting of Equity shares) Regulation, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/common/CorporateAnnouncements).

Acropetal Technologies Limited has submitted to the Exchange, the financial results for the period ended 31-Mar-2017.

Acropetal Technologies Limited has submitted to the Exchange, the financial results for the period ended 31-Dec-2016.

Acropetal Technologies Limited has submitted to the Exchange, the financial results for the period ended 30-Sep-2016.

Acropetal Technologies Limited has submitted to the Exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended June 30, 2016.

Acropetal Technologies Limited has submitted to the Exchange the standalone & consolidated financial results for the period ended March 31, 2016.

Acropetal Technologies Limited has submitted to the Exchange the standalone and consolidated financial results along with the Auditors Report for the period ended 31-Mar-2016.

Acropetal Technologies Limited has informed the Exchange that the Trading Window for dealing in securities of the Company will remain closed for all Directors, Officers and Designated Employees from May 24, 2016 to June 01, 2016 (both days inclusive).

Acropetal Technologies Limited has submitted to the Exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended December 31, 2015.

Acropetal Technologies Limited has informed the Exchange that the Trading Window for dealing in securities of the Company will remain closed for all Directors, Officers and Designated Employees from February 4, 2016 to February 11, 2016 (both days inclusive).

Acropetal Technologies Limited has informed the Exchange regarding the Outcome of Board Meeting of the Company held on December 31, 2015.

Acropetal Technologies Limited has submitted to the Exchange a copy of voting results on the Ordinary/ Special Resolution approved at the Annual General Meeting of the members of the Company held on November 24, 2015, along with a copy of Scrutinizer's Report pursuant to Clause 35A of the Listing Agreement.

Acropetal Technologies Limited has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the Company held on November 24, 2015.

Acropetal Technologies Limited has submitted to the exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended 30-Sep-2015.

Acropetal Technologies Limited has informed the Exchange that the register of members and share transfer books of the Company shall remain closed from November 18, 2015 to November 24, 2015(both dates inclusive) for the purpose of Annual General Meeting of the Company to be held on November 24, 2015.

Acropetal Technologies Limited has informed the Exchange that the Trading Window of the Shares of the Company will remain closed in terms of the Code of Conduct to Regulate, Monitor and Report Trading by Insiders formulated pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015, from October 30, 2015 to November 09, 2015 (both days inclusive) in connection with the meeting of the Board of Directors of the Company.

Acropetal Technologies Limited has informed the Exchange that the Board of Directors in their meeting held on September 16, 2015 have taken the decision to apply to the Register of Companies Karnataka for extension of time of three months to hold the Annual General Meeting of the company for business reasons.

Acropetal Technologies Limited has submitted to the exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended 30-Jun-2015.

Acropetal Technologies Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-Mar-2015.

Acropetal Technologies Limited has informed the Exchange that the Trading Window of the Shares of the Company will remain closed in terms of the Code of Conduct to Regulate, Monitor and Report Trading by Insiders formulated pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015, from May 22, 2015 to June 01, 2015 (both days inclusive) in connection with the meeting of the Board of Directors of the Company on May 29, 2015, inter alia, to consider and approve the Audited Financial Results of the Company for the quarter ended March 31, 2015, and also

Ravi Kumar (HUF) has submitted to the Exchange vide letter dated April 01, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Malini Reddy T has submitted to the Exchange vide letter dated April 01, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Dorai Swamy K has submitted to the Exchange vide letter dated April 01, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

D. Ravi Kumar has submitted to the Exchange vide letter dated April 01, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Acropetal Technologies Limited has submitted to the exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended 31-Dec-2014.

Acropetal Technologies Limited has informed the Exchange that the Trading Window of the Shares of the Company will remain closed from January 29, 2015 to February 06, 2015 (both days inclusive) in connection with the meeting of the Board of Directors of the Company on February 05, 2015, inter alia, to consider and approve the Un-Audited Financial Results of the Company for the quarter and nine months period ended December 31, 2014, both on stand alone and on consolidated basis.

Acropetal Technologies Limited has submitted to the Exchange a copy of minutes of the Annual General Meeting of the Company held on September 29, 2014.

Acropetal Technologies Limited has submitted to the exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended 30-Sep-2014.

Acropetal Technologies Limited has submitted to the Exchange a copy of voting results of Annual General Meeting held on September 29, 2014 along with Report of Scrutinizer pursuant to clause 35A of the Listing Agreement.

Acropetal Technologies Limited has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the Company held on September 29, 2014.

Acropetal Technologies Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2014 to September 29, 2014 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on September 29, 2014.

Acropetal Technologies Limited has informed the Exchange that the Board of Directors in the meeting held on August 14, 2014, accepted the Resignation of Mr. Mohan Hosahalli Ramakrishna, Director of the Company effective from May 14, 2014. He was also the Chairman of the Audit Committee and a member in Remuneration Committee and Shareholders Grievance Committee of the Company.

Acropetal Technologies Limited has submitted to the exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended 30-Jun-2014.

Acropetal Technologies Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-Mar-2014.

Acropetal Technologies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 11, 2014, accepted the Resignation of Dr. Mathew James Manimala, Director of the Company effective from December 09, 2013. He was also the Chairman of Remuneration Committee of the Company.

Acropetal Technologies Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-dec-2013.

Acropetal Technologies Limited has submitted to the Exchange a copy of Minutes of Annual General Meeting of the Company held on December 26, 2013.

Acropetal Technologies Limited has informed the Exchange regarding the details of the voting results on the Ordinary/ Special Resolution approved at the Annual General Meeting of the members of the Company held on December 26, 2013. (as per clause 35A)

Acropetal Technologies Limited has informed the Exchange regarding the outcome of the Annual General Meeting of the Company held on December 26, 2013.

Acropetal Technologies Limited has informed the Exchange that the Annual General Meeting of the Company will be held on December 26, 2013. Further, the Register of Members and Share Transfer Books of the Company will remain closed from December 19, 2013 to December 26, 2013 (both days inclusive) for the purpose of the Annual General Meeting of the Company scheduled on December 26, 2013.

Acropetal Technologies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on November 12, 2013, has approved the following: (1) Appointment of Dr. M. Madhu Sudhana Reddy as Additional Director with effect from November 12, 2013. He is an Independent Director. (2) Appointment of Mr. Mohan Hosahally Ramakrishna, an Independent Director, as the Chairman of the Audit Committee. (3) Appointment of Mr. D Ravi Kumar, the Chairman and Managing Director as a Member of the Audit Committee. (4) Appointment of Dr. D K Subrahmanya Reddy, an Independent Director

Acropetal Technologies Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 30-Sep-2013.

Acropetal Technologies Limited has informed the Exchange that the Registrar of Companies, Karnataka has granted extension of time to the Company to hold the Annual General Meeting of the Company up to December 27, 2013.

Acropetal Technologies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 08, 2013, inter alia, has taken following decision: 1) Apply to the Registrar of Companies Karnataka for extension of time of three months to hold the Annual General Meeting of the Company for business reasons.

Acropetal Technologies Limited has informed the Exchange vide letter dated August 08, 2013, regarding Withdrawal of amalgamation application/petition - intimation of court order disposing the withdrawal application/petition.

Acropetal Technologies Limited has submitted to the Exchange the Standalone and Consolidated Financial Results along with the Limited Review Report for the period ended June 30,2013.

Acropetal Technologies Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 29, 2013 have inter-alia taken the decisions as under : (1) Decided to dispose off/ divest equity shares to the maximum extent of 3% i.e. upto 30,000 equity shares of Kinfotech Private Limited. On disposal of the said shares, Kinfotech Private Limited ceases to be the subsidiary of Acropetal Technologies Ltd.(2). In view of the changed business scenario between the date of applying for approval of the Scheme of Amalgamation of Kinfotech Private Limited and MindRiver In

Acropetal Technologies Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended March 31,2013.

Acropetal Technologies Limited has submitted to the Exchange the Standalone and Consolidated Financial Results along with the Limited Review Report for the period ended December 31,2012.